TL;DR

Regenerative treatments such as platelet-rich plasma (PRP) and prolotherapy may support tendon repair in conditions like Achilles tendinopathy, patellar tendinopathy, and tennis elbow by delivering biologic signals to the injured tissue. They work best alongside rehabilitation that addresses the mechanical causes of the overuse injury. Candidacy requires a full clinical evaluation.

If you’re comparing treatments, start with the clinic’s overview of regenerative medicine options before discussing your options with a clinician.

Key takeaways

• Tendinopathy involves collagen breakdown in the tendon and often does not respond well to cortisone alone, which does not address underlying tissue disrepair.
• Regenerative options like PRP and prolotherapy aim to support the body's own repair process, but evidence varies by tendon and protocol, and results depend heavily on correcting underlying mechanical factors.
• A thorough clinical evaluation, including diagnostic imaging, is essential before choosing any biologic treatment for a tendon injury.

What Is Tendinopathy and Why Is It So Hard to Treat?

Tendinopathy is a breakdown in the structure of a tendon, the thick cord of fibrous tissue that connects muscle to bone. Unlike a sudden tendon tear, tendinopathy develops gradually from repetitive loading and often resists standard treatments.

Achilles tendinopathy, patellar tendinopathy (sometimes called jumper's knee), and lateral epicondylosis (tennis elbow) are among the most common overuse injuries seen in active adults and athletes. Pickleball players, runners, tennis players, and weekend golfers on Long Island all know the feeling: a nagging ache that never quite resolves, even after rest and physical therapy.

The reason tendinopathy is stubborn is partly biological. Tendons have a relatively poor blood supply compared with muscle tissue. When microscopic collagen fibers inside the tendon break down faster than the body can repair them, a degenerative pattern called tendinosis develops. Cortisone injections can reduce short-term inflammation but do not address the underlying tissue disrepair, and repeated cortisone use has been associated with further tendon weakening, according to research cited by the American Academy of Orthopaedic Surgeons (AAOS).

How Regenerative Approaches Work for Damaged Tendons

Regenerative treatments aim to deliver concentrated biologic signals directly into the injured tendon to support the natural repair process, rather than simply reducing pain signals.

The underlying idea is straightforward: the body already knows how to heal, but a poorly vascularized tendon sometimes needs help getting the right signals to the right place. Biologic treatments such as platelet-rich plasma (PRP) concentrate growth factors from the patient's own blood and introduce them to the site of injury. Prolotherapy uses a precisely placed irritant solution to trigger a localized healing response in weakened connective tissue.

These approaches do not replace the tendon or guarantee new collagen growth. They are intended to create a biological environment in which the body's own repair mechanisms can work more effectively. When delivered under ultrasound guidance, the clinician can confirm the needle is precisely placed at the area of tendon pathology, improving the accuracy of the treatment.

PRP, Prolotherapy, and Other Biologic Options Explained

Platelet-rich plasma (PRP) and prolotherapy are the two most commonly used regenerative options for tendinopathy. Each works through a different mechanism and suits different clinical situations.

PRP is prepared by drawing a small amount of the patient's blood, spinning it in a centrifuge to concentrate the platelets, and injecting the resulting solution into the injured tendon. Platelets carry growth factors, including platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta), that play a role in tissue repair and collagen synthesis.

Prolotherapy involves injecting a solution, often dextrose-based, into the tendon or its attachment point at the bone. The mild irritant response is thought to stimulate fibroblast activity, the cells responsible for producing collagen. Some clinicians combine approaches depending on the degree of tendon involvement.

Neither option is a quick fix. Both typically require a structured plan that includes a period of relative rest, a graded return to activity, and often continued physical therapy. The choice between them, and whether either is appropriate at all, depends on a thorough clinical evaluation.

Why Biomechanics Matter as Much as the Injection

A regenerative injection alone rarely produces lasting results if the movement patterns, muscle imbalances, or training loads that caused the tendon injury are not also addressed.

This point is worth being direct about. Dr. Jordan Sudberg, MD, Physiatrist and Pain Management Specialist at Spine and Sports Rehab NY on Long Island, puts it plainly: "Regenerative medicine isn't a one-size-fits-all miracle fix; without correcting underlying mechanical imbalances and structural stressors first, biologic treatments won't achieve lasting tissue repair."

For a runner with Achilles tendinopathy, that might mean assessing foot mechanics, calf flexibility, and training volume before any injection is considered. For a tennis player with lateral epicondylosis, it could involve analyzing grip mechanics and shoulder function. The injection creates a biological opportunity. The rehabilitation work is what allows the tendon to reorganize that new tissue under appropriate load. Skipping the mechanical assessment and going straight to a biologic treatment is a common reason patients do not get the results they hoped for.

What the Evidence Currently Shows

The evidence for regenerative treatments in tendinopathy is promising but still evolving. Results vary by tendon location, treatment protocol, patient health, and how treatment is combined with rehabilitation.

Multiple randomized controlled trials and systematic reviews have examined PRP for Achilles and patellar tendinopathy, as well as for lateral epicondylosis. Findings are mixed, partly because PRP preparation methods differ across studies, making direct comparisons difficult. A 2021 review published in the British Journal of Sports Medicine found that leukocyte-rich PRP showed benefit for lateral epicondylosis in several trials, while results for Achilles tendinopathy were more variable.

Dr. Jordan Sudberg, MD, captures the clinical reality well: "Regenerative medicine should not be viewed as a one-size-fits-all solution. The important question is whether a particular regenerative treatment is appropriate for the individual patient and the specific tissue or condition being treated." That means the strength of the evidence for a given tendon, combined with the individual patient's history and goals, guides the recommendation, not a general enthusiasm for biologics.

This is why a thorough evaluation, including diagnostic imaging when needed, is the right starting point before any regenerative treatment is discussed.

Is Regenerative Treatment Right for Your Tendon Injury?

Candidacy for regenerative treatment depends on the specific tendon involved, the degree of structural change, previous treatments tried, overall health, and individual goals.

Not every tendon injury is a good candidate for biologic treatment. Tendons that have progressed to a full structural tear, or injuries associated with significant bony changes, may require a different approach. Patients taking certain medications, or those with specific medical conditions, may also not be suitable candidates.

A physiatrist (a physician specializing in physical medicine and rehabilitation) or sports medicine physician is well positioned to evaluate overuse tendon injuries because their training focuses on function, the full musculoskeletal chain, and nonsurgical options first. Diagnostic ultrasound, performed in the office, can visualize tendon structure and identify the precise area of pathology, which guides both diagnosis and any subsequent injection.

If you have been living with persistent tendon pain that has not responded to rest, physical therapy, or prior injections, an evaluation focused on the source of the problem, not just symptom management, is a reasonable next step. Please consult a qualified clinician about your individual situation before pursuing any treatment.

Frequently asked questions

Can PRP treat Achilles tendinopathy?

PRP has been studied as a treatment for Achilles tendinopathy with mixed results across clinical trials. Whether it is appropriate depends on the extent of tendon involvement, previous treatments, and individual health factors. A physiatrist or sports medicine physician can evaluate your specific situation.

How many regenerative injections are needed for a tendon injury?

The number of treatments varies by tendon location, severity of the injury, and which biologic approach is used. A clinical evaluation is needed to develop an individualized treatment plan. Do not attempt self-treatment or make decisions based on general estimates.

Is regenerative treatment better than cortisone for tendon pain?

Cortisone reduces short-term inflammation but does not address underlying tendon tissue breakdown and may weaken the tendon with repeated use. Regenerative options like PRP aim to support tissue repair, but the right choice depends on the individual patient and condition.

Do I need surgery if regenerative treatment does not work?

Not necessarily. There are several nonsurgical options that may be considered before surgery is discussed. A thorough evaluation by a physician specializing in nonsurgical musculoskeletal care can help map out the full range of options appropriate for your situation.